Nipro Co. (OTCMKTS:NPRRF) Sees Significant Growth in Short Interest

Nipro Co. (OTCMKTS:NPRRFGet Free Report) was the recipient of a large growth in short interest in the month of July. As of July 31st, there was short interest totaling 95,787 shares, a growth of 78.2% from the July 15th total of 53,746 shares. Based on an average trading volume of 0 shares, the short-interest ratio is presently ∞ days.

Nipro Stock Performance

Shares of Nipro stock remained flat at $9.96 on Tuesday. The company’s fifty day moving average is $9.96 and its two-hundred day moving average is $9.67. Nipro has a 1-year low of $9.67 and a 1-year high of $9.96.

Nipro Company Profile

(Get Free Report)

Nipro Corporation, together with its subsidiaries, engages in the medical devices, pharmaceuticals, and pharma packaging businesses. Its Medical Device business develops, manufactures, and sells medical equipment for injection-infusion and dialysis treatment, and products related to diabetes and cell cultures, as well as the sale of artificial organ-related products. The company's Pharmaceutical business provides pharmaceutical combination products, including dual chamber bags, pre-filled syringes, and half-type kits; and contract manufacturing services for orally administered drugs, injectables, and external preparations, as well as logistic and distribution services.

See Also

Receive News & Ratings for Nipro Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nipro and related companies with MarketBeat.com's FREE daily email newsletter.